Gene · 6892
Papers1,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of 5-inflammatory-gene signature to affect the immune status and predict prognosis in breast cancer. | Cent Eur J Immunol | 2022 | 36817270 | PubTator, text mining | PubMed |
| Spondyloarthritides: Theories and beyond. | Front Pediatr | 2022 | 36619518 | PubTator, text mining | PubMed |
| The Intracellular Proteome as a Source for Novel Targets in CAR-T and T-Cell Engagers-Based Immunotherapy. | Cells | 2022 | 36611821 | PubTator, text mining | PubMed |
| Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cells. | J Immunother Cancer | 2022 | 36600602 | PubTator, text mining | PubMed |
| Cancer immune profiling unveils biomarkers, immunological pathways, and cell type score associated with glioblastoma patients' survival. | Ther Adv Med Oncol | 2022 | 36579028 | PubTator, text mining | PubMed |
| Identification of β2 microglobulin, the product of B2M gene, as a Host Factor for Vaccinia Virus Infection by Genome-Wide CRISPR genetic screens. | PLoS Pathog | 2022 | 36574441 | PubTator, text mining | PubMed |
| Langerhans Cells-Revising Their Role in Skin Pathologies. | J Pers Med | 2022 | 36556292 | PubTator, text mining | PubMed |
| Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG. | Cells | 2022 | 36552831 | PubTator, text mining | PubMed |
| Human leukocyte antigen super-locus: nexus of genomic supergenes, SNPs, indels, transcripts, and haplotypes. | Hum Genome Var | 2022 | 36543786 | PubTator, text mining | PubMed |
| Single-cell transcriptomics highlights immunological dysregulations of monocytes in the pathobiology of COPD. | Respir Res | 2022 | 36539833 | PubTator, text mining | PubMed |
| Immune landscape-based machine-learning-assisted subclassification, prognosis, and immunotherapy prediction for glioblastoma. | Front Immunol | 2022 | 36532035 | PubTator, text mining | PubMed |
| Galectin-9 expression clinically associated with mature dendritic cells infiltration and T cell immune response in colorectal cancer. | BMC Cancer | 2022 | 36527024 | PubTator, text mining | PubMed |
| Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma. | J Transl Med | 2022 | 36522647 | PubTator, text mining | PubMed |
| Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer. | World J Surg Oncol | 2022 | 36517818 | PubTator, text mining | PubMed |
| Reduced MHC Class I and II Expression in HPV-Negative vs. HPV-Positive Cervical Cancers. | Cells | 2022 | 36497170 | PubTator, text mining | PubMed |
| Novel Role of Mammalian Cell Senescence-Sustenance of Muscle Larvae of Trichinella spp. | Oxid Med Cell Longev | 2022 | 36478989 | PubTator, text mining | PubMed |
| Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response. | Sci Adv | 2022 | 36475797 | PubTator, text mining | PubMed |
| MLSP: A bioinformatics tool for predicting molecular subtypes and prognosis in patients with breast cancer. | Comput Struct Biotechnol J | 2022 | 36467575 | PubTator, text mining | PubMed |
| The β-carboline Harmine improves the therapeutic benefit of anti-PD1 in melanoma by increasing the MHC-I-dependent antigen presentation. | Front Immunol | 2022 | 36458012 | PubTator, text mining | PubMed |
| Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response. | NPJ Precis Oncol | 2022 | 36456685 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6892/papers?page=12